The Use of Artificial Intelligence and Wearable Inertial Measurement Units in Medicine: Systematic Review (Preprint)

Ricardo Smits Serena, Florian Hinterwimmer, Rainer Burgkart, Rüdiger von Eisenhart‐Rothe, Daniel Rueckert2024 · DOI

TL;DR

This systematic review analyzes 122 studies to map the current landscape of AI and wearable Inertial Measurement Units (IMUs) in medicine. While the field shows immense promise for disease monitoring and diagnosis—particularly in neurology—it is currently bottlenecked by small dataset sizes (median of 50 participants) and a heavy reliance on supervised learning in controlled clinical settings rather than real-world environments.

What Problem Does This Paper Address?

Wearable sensors like accelerometers and gyroscopes (IMUs) are now ubiquitous in consumer electronics, yet their integration into clinical practice remains a challenge. The core difficulty lies in transforming high-dimensional, noisy motion data into actionable medical insights.

The authors identify a significant gap between the potential of AI to revolutionize personalized healthcare and the current reality of research. This paper systematically evaluates which medical fields are leading the charge, which AI architectures are most prevalent, and the characteristics of the data being used. By doing so, it highlights the technical and methodological hurdles—such as data labeling costs and lack of standardization—that prevent these technologies from moving from the lab to the bedside.

Methods

The researchers conducted a systematic review following PRISMA guidelines, searching PubMed and Web of Science for studies published up to November 2023.

To ensure high-quality analysis, they applied strict inclusion criteria:

  • Studies must use one or more IMUs.
  • They must target a specific clinical condition.
  • They must employ Machine Learning (ML) or Deep Learning (DL) for data analysis.
  • A minimum of 20 participants was required to ensure statistical relevance.

The authors then categorized the 122 qualifying papers by medical specialty, the purpose of the AI (e.g., detection vs. monitoring), the specific models used, and the study setting (clinical vs. real-life).

Datasets

The paper does not introduce a new dataset but provides a meta-analysis of the datasets used across the reviewed literature.

  • Median Dataset Size: 50.5 participants (IQR 54). This is notably small for training robust AI models.
  • Setting: 77% of studies were conducted in clinical or laboratory settings, while only a small fraction utilized "real-life" or hybrid environments.
  • Field-Specific Sizes: Otolaryngology had the largest median dataset (103 participants), while General and Preventive Medicine had the smallest (24 participants).
  • The "Data Width" Problem: The authors note a trend where researchers prioritize "data width" (more features/sensors per person) over "data length" (more participants), which often leads to overfitting in complex models.

Key Insights and Ideas

  • Neurology is the "Early Adopter": Nearly 65% of the studies focused on neurological conditions (like Parkinson’s or stroke). This is likely because movement disorders provide "cleaner" signal patterns in IMU data that are easier for current algorithms to classify.
  • The Supervised Learning Trap: An overwhelming 93% of studies used supervised learning. While effective, this requires labor-intensive manual labeling by clinicians. The authors argue that unsupervised learning is a massive, untapped opportunity for discovering new, non-obvious biomarkers without predefined labels.
  • Traditional ML Still Outpaces Deep Learning: Despite the hype around Deep Learning (DL), traditional Machine Learning (ML) models like Support Vector Machines (50%) and Random Forests (35.2%) remain the standard. This is largely due to the small dataset sizes; DL typically requires much larger cohorts to outperform simpler, feature-engineered models.
  • The "Clinical Bubble": Most research happens in controlled environments. However, the true value of wearables lies in continuous, long-term monitoring in the "wild." The transition to real-world data is currently hindered by battery life, data storage, and patient compliance.

Key Results

  • Top Models: Support Vector Machines (SVM) were the most prevalent (used in 61 studies), followed by Random Forest (43) and k-Nearest Neighbors (25).
  • Deep Learning Trends: Convolutional Neural Networks (CNN) led the DL category (20 studies), followed by Multilayer Perceptrons (10) and LSTMs (9).
  • Primary AI Purposes:
    • Disease Monitoring: 31.1%
    • Disease Severity Assessment: 19.6%
    • Risk Prediction/Prevention: 14.7%
  • Average Model Usage: On average, each study tested 2.67 different AI models, indicating a high level of experimentation as researchers search for the "best" architecture for motion data.

Limitations and Future Work

The authors acknowledge several critical limitations in the current state of the field:

  • Scalability: The small median dataset size (50 participants) severely limits the generalizability of the findings.
  • Lack of Benchmarks: There are no standardized benchmarks or protocols for IMU-based AI, making it nearly impossible to compare the performance of different models across studies.
  • Hardware Constraints: Current wearable technology often suffers from inadequate battery life and storage for high-frequency, long-term medical data collection.

Future Directions: The review calls for multi-institutional collaborations to build larger, diverse datasets. It also suggests a shift toward unsupervised and self-supervised learning to reduce the burden of data labeling and an expansion of research into musculoskeletal and orthopedic applications where AI-driven motion analysis could significantly improve surgical outcomes and rehabilitation.

Summary updated

Abstract

<sec> <title>BACKGROUND</title> Artificial intelligence (AI) has already revolutionized the analysis of image, text, and tabular data, bringing significant advances across many medical sectors. Now, by combining with wearable inertial measurement units (IMUs), AI could transform health care again by opening new opportunities in patient care and medical research. </sec> <sec> <title>OBJECTIVE</title> This systematic review aims to evaluate the integration of AI models with wearable IMUs in health care, identifying current applications, challenges, and future opportunities. The focus will be on the types of models used, the characteristics of the datasets, and the potential for expanding and enhancing the use of this technology to improve patient care and advance medical research. </sec> <sec> <title>METHODS</title> This study examines this synergy of AI models and IMU data by using a systematic methodology, following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, to explore 3 core questions: (1) Which medical fields are most actively researching AI and IMU data? (2) Which models are being used in the analysis of IMU data within these medical fields? (3) What are the characteristics of the datasets used for in this fields? </sec> <sec> <title>RESULTS</title> The median dataset size is of 50 participants, which poses significant limitations for AI models given their dependency on large datasets for effective training and generalization. Furthermore, our analysis reveals the current dominance of machine learning models in 76% on the surveyed studies, suggesting a preference for traditional models like linear regression, support vector machine, and random forest, but also indicating significant growth potential for deep learning models in this area. Impressively, 93% of the studies used supervised learning, revealing an underuse of unsupervised learning, and indicating an important area for future exploration on discovering hidden patterns and insights without predefined labels or outcomes. In addition, there was a preference for conducting studies in clinical settings (77%), rather than in real-life scenarios, a choice that, along with the underapplication of the full potential of wearable IMUs, is recognized as a limitation in terms of practical applicability. Furthermore, the focus of 65% of the studies on neurological issues suggests an opportunity to broaden research scope to other clinical areas such as musculoskeletal applications, where AI could have significant impacts. </sec> <sec> <title>CONCLUSIONS</title> In conclusion, the review calls for a collaborative effort to address the highlighted challenges, including improvements in data collection, increasing dataset sizes, a move that inherently pushes the field toward the adoption of more complex deep learning models, and the expansion of the application of AI models on IMU data methodologies across various medical fields. This approach aims to enhance the reliability, generalizability, and clinical applicability of research findings, ultimately improving patient outcomes and advancing medical research. </sec>
BibTeX
@misc{serena2024use,
  author = {Ricardo Smits Serena and Florian Hinterwimmer and Rainer Burgkart and Rüdiger von Eisenhart‐Rothe and Daniel Rueckert},
  title = {{The Use of Artificial Intelligence and Wearable Inertial Measurement Units in Medicine: Systematic Review (Preprint)}},
  year = {2024},
  doi = {10.2196/preprints.60521},
}
Figure